In vitro activities of new antimicrobial agents against multiresistant Staphylococcus aureus isolated from septicemic patients during a Belgian national survey from 1983 to 1985
Open Access
- 1 November 1990
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 34 (11), 2260-2262
- https://doi.org/10.1128/aac.34.11.2260
Abstract
The antimicrobial agents most active against bacteremic isolates of oxacillin-resistant Staphylococcus aureus isolated from 1983 to 1985 were new fluoroquinolones, including PD 117,596 and PD 127,391 (MIC for 90% of isolates [MIC90] in agar, in micrograms per milliliter, 0.1) and temafloxacin, pefloxacin, and ofloxacin (MIC90, 0.4). Other active antimicrobial agents included fusidic acid (MIC90, 0.2) and fosfomycin (MIC90, 12.5). Vancomycin was active against all isolates. Mupirocin was very active (MIC90, 0.4).Keywords
This publication has 8 references indexed in Scilit:
- Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospitalAntimicrobial Agents and Chemotherapy, 1989
- Mechanism of mupirocin transport into sensitive and resistant bacteriaAntimicrobial Agents and Chemotherapy, 1989
- In vitro activities of PD 117,596 and reference antibiotics against 448 clinical bacterial strainsAntimicrobial Agents and Chemotherapy, 1988
- Comparative in vitro activity of PD 127,391, a new fluorinated 4-quinolone derivativeAntimicrobial Agents and Chemotherapy, 1988
- In vitro activity of PD 127,391, an enhanced-spectrum quinoloneAntimicrobial Agents and Chemotherapy, 1988
- In-vitro activity of two new carbapenems FCE 22101 and CGP 31608 in comparison with imipenemJournal of Antimicrobial Chemotherapy, 1987
- MupirocinDrugs, 1986
- A general survey of antibiotic treatment of staphylococcal septicaemia and endocarditis.1983